[Treatment guidelines for deep venous thrombosis and pulmonary embolus].
Harjola
V P
VP
HYKS:n sisätautien klinikka, päivystys ja valvonta Meilahden sairaala PL 340, 00029 HYKS. veli-pekka.harjola@hus.fi
Teittinen
J
J
D000925:Anticoagulants / Q000627:therapeutic use*; D001777:Blood Coagulation / Q000187:drug effects; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D006801:Humans; D017410:Practice Guidelines as Topic; D011655:Pulmonary Embolism / Q000188:drug therapy* / Q000209:etiology / Q000517:prevention & control; D012720:Severity of Illness Index; D016306:Vena Cava Filters; D020246:Venous Thrombosis / Q000150:complications / Q000188:drug therapy*; D014859:Warfarin / Q000627:therapeutic use
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight; D014859:Warfarin